메뉴 건너뛰기




Volumn 13, Issue 1, 2008, Pages 41-45

The use of recombinant activated factor VII in platelet-associated bleeding

Author keywords

Bleeding; Inherited and acquired; Platelets; rVlla

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBODY; ANTIFIBRINOLYTIC AGENT; CLOPIDOGREL; FIBRIN GLUE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOGEN RECEPTOR ANTIBODY; HLA ANTIBODY; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

EID: 48449106178     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453308X315816     Document Type: Review
Times cited : (9)

References (40)
  • 1
    • 17944368846 scopus 로고    scopus 로고
    • Recombinant activated factor VII (rFVIIa): Characterization, manufacturing and clinical development
    • Jurlander B, Thim L, Klausen NK et al. Recombinant activated factor VII (rFVIIa): Characterization, manufacturing and clinical development. Semin Thromb Hemost 2001; 27: 373-383.
    • (2001) Semin Thromb Hemost , vol.27 , pp. 373-383
    • Jurlander, B.1    Thim, L.2    Klausen, N.K.3
  • 2
    • 0036363842 scopus 로고    scopus 로고
    • Potential role for rFVIIa in transfusion medicine
    • Hedner U, Erhardtsen E. Potential role for rFVIIa in transfusion medicine. Transfusion 2002; 42: 114-124.
    • (2002) Transfusion , vol.42 , pp. 114-124
    • Hedner, U.1    Erhardtsen, E.2
  • 3
    • 3242709784 scopus 로고    scopus 로고
    • Recombinant activated factor VIII for non-hemophiliac bleeding patients
    • Uhlmann EJ, Eby CS. Recombinant activated factor VIII for non-hemophiliac bleeding patients. Curr Opin Hematol 2004; 11: 198-204.
    • (2004) Curr Opin Hematol , vol.11 , pp. 198-204
    • Uhlmann, E.J.1    Eby, C.S.2
  • 4
    • 20444452505 scopus 로고    scopus 로고
    • Recombinant factor VIIa. An update on its clinical use
    • Franchini M, Zaffanello M, Veneri D. Recombinant factor VIIa. An update on its clinical use. Thromb Haemost 2005; 93: 1027-1035
    • (2005) Thromb Haemost , vol.93 , pp. 1027-1035
    • Franchini, M.1    Zaffanello, M.2    Veneri, D.3
  • 5
    • 0033784063 scopus 로고    scopus 로고
    • New products for managing inhibitors to coagulation factors: A focus on recombinant factor VIIa concentrate
    • Kessler CM. New products for managing inhibitors to coagulation factors: a focus on recombinant factor VIIa concentrate. Curr Opin Hematol 2000; 7: 408-413.
    • (2000) Curr Opin Hematol , vol.7 , pp. 408-413
    • Kessler, C.M.1
  • 6
    • 6344239341 scopus 로고    scopus 로고
    • Off-license' use of recombinant activated factor VII
    • Ghorashian S, Hunt BJ. 'Off-license' use of recombinant activated factor VII. Blood Rev 2004; 18: 245-259.
    • (2004) Blood Rev , vol.18 , pp. 245-259
    • Ghorashian, S.1    Hunt, B.J.2
  • 7
    • 6344291879 scopus 로고    scopus 로고
    • The use of rFVIIa in non-haemophilia bleeding conditions in paediatrics
    • Mathew P. The use of rFVIIa in non-haemophilia bleeding conditions in paediatrics. Thromb Haemost 2004; 92: 738-746.
    • (2004) Thromb Haemost , vol.92 , pp. 738-746
    • Mathew, P.1
  • 8
    • 0346921344 scopus 로고    scopus 로고
    • Mechanism of action of recombinant factor VIIa
    • Lisman T, De Groot PG. Mechanism of action of recombinant factor VIIa. J Thromb Haemost 2003; 1: 1138-1139.
    • (2003) J Thromb Haemost , vol.1 , pp. 1138-1139
    • Lisman, T.1    De Groot, P.G.2
  • 9
    • 19044370248 scopus 로고    scopus 로고
    • Treatment of bleeding in patients with platelet disorders: Is there a place for recombinant factor VIIa?
    • Laurian Y. Treatment of bleeding in patients with platelet disorders: Is there a place for recombinant factor VIIa? Pathophysiol Haemost Thromb 2002; 32: 37-40
    • (2002) Pathophysiol Haemost Thromb , vol.32 , pp. 37-40
    • Laurian, Y.1
  • 10
    • 0032698580 scopus 로고    scopus 로고
    • Inherited abnormalities of platelets
    • Nurden AT. Inherited abnormalities of platelets. Thromb Haemost 1999; 82: 468-480.
    • (1999) Thromb Haemost , vol.82 , pp. 468-480
    • Nurden, A.T.1
  • 11
    • 0029961868 scopus 로고    scopus 로고
    • A patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant factor VIIa
    • Tengborn L, Petruson B. A patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant factor VIIa. Thromb Haemost 1996; 75: 981-982.
    • (1996) Thromb Haemost , vol.75 , pp. 981-982
    • Tengborn, L.1    Petruson, B.2
  • 12
    • 0032703537 scopus 로고    scopus 로고
    • Successful epistaxis control in a patient with Glanzmann thrombasthenia by increased bolus injection dose of recombinant factor VIIa
    • Chuansumrit A, Sangkapreecha C, Hathirat P. Successful epistaxis control in a patient with Glanzmann thrombasthenia by increased bolus injection dose of recombinant factor VIIa. Thromb Haemost 1999; 82: 1778.
    • (1999) Thromb Haemost , vol.82 , pp. 1778
    • Chuansumrit, A.1    Sangkapreecha, C.2    Hathirat, P.3
  • 13
    • 0033485862 scopus 로고    scopus 로고
    • Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia
    • Poon MC, Demers C, Jobin F, Wu JW. Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia. Blood 1999; 94: 3951-3953.
    • (1999) Blood , vol.94 , pp. 3951-3953
    • Poon, M.C.1    Demers, C.2    Jobin, F.3    Wu, J.W.4
  • 14
    • 0034041468 scopus 로고    scopus 로고
    • Recombinant activated factor VII (NovoSeven) treatment of platelet-related bleeding disorders. International Registry on Recombinant Factor VIIa and Congenital Platelet Disorders Group
    • Poon MC, D'Oiron R. Recombinant activated factor VII (NovoSeven) treatment of platelet-related bleeding disorders. International Registry on Recombinant Factor VIIa and Congenital Platelet Disorders Group. Blood Coagul Fibrinolysis 2000; 11 (Suppl. 1): S55-S68.
    • (2000) Blood Coagul Fibrinolysis , vol.11 , Issue.SUPPL. 1
    • Poon, M.C.1    D'Oiron, R.2
  • 15
    • 0035198814 scopus 로고    scopus 로고
    • Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia
    • Poon MC, D'Oiron R, Hann I et al. Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia. Semin Hematol 2001; 33: 21-25.
    • (2001) Semin Hematol , vol.33 , pp. 21-25
    • Poon, M.C.1    D'Oiron, R.2    Hann, I.3
  • 16
    • 19944431107 scopus 로고    scopus 로고
    • Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: Results of an international survey
    • Poon MC, D'Oiron R, Von Depka M, et al. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: Results of an international survey. J Thromb Haemost 2004; 2: 1096-1103.
    • (2004) J Thromb Haemost , vol.2 , pp. 1096-1103
    • Poon, M.C.1    D'Oiron, R.2    Von Depka, M.3
  • 17
    • 0042427773 scopus 로고    scopus 로고
    • Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia
    • Caglar K, Cetinkaya A, Aytac S, Gumruk F, Gurgey A. Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia. Pediatr Hematol Oncol 2003; 20: 435-438.
    • (2003) Pediatr Hematol Oncol , vol.20 , pp. 435-438
    • Caglar, K.1    Cetinkaya, A.2    Aytac, S.3    Gumruk, F.4    Gurgey, A.5
  • 18
    • 0141673285 scopus 로고    scopus 로고
    • Confirmation of high dose recombinant factor VIIa in treating patients with Glanzmann thrombasthenia
    • Chuansumrit A. Confirmation of high dose recombinant factor VIIa in treating patients with Glanzmann thrombasthenia. J Thromb Haemost 2003; 1: 396.
    • (2003) J Thromb Haemost , vol.1 , pp. 396
    • Chuansumrit, A.1
  • 19
    • 0037298416 scopus 로고    scopus 로고
    • Recombinant activated factor VII combined with local measures in preventing bleeding from invasive dental procedures in patients with Glanzmann thrombasthenia
    • Chuansumrit A, Suwannuraks M, Sri-Udomporn N, Pongtanakul B, Worapongpaiboon S. Recombinant activated factor VII combined with local measures in preventing bleeding from invasive dental procedures in patients with Glanzmann thrombasthenia. Blood Coagul Fibrinolysis 2003; 14: 187-190.
    • (2003) Blood Coagul Fibrinolysis , vol.14 , pp. 187-190
    • Chuansumrit, A.1    Suwannuraks, M.2    Sri-Udomporn, N.3    Pongtanakul, B.4    Worapongpaiboon, S.5
  • 20
    • 0038015845 scopus 로고    scopus 로고
    • The use of recombinant factor VIIa in children with inherited platelet function disorders
    • Almeida A, Khair K, Hann I, Liesner R. The use of recombinant factor VIIa in children with inherited platelet function disorders. Br J Haematol 2003; 121: 477-481.
    • (2003) Br J Haematol , vol.121 , pp. 477-481
    • Almeida, A.1    Khair, K.2    Hann, I.3    Liesner, R.4
  • 21
    • 0034062832 scopus 로고    scopus 로고
    • Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thromboasthenia undergoing invasive procedures
    • D'Oiron R, Menart C, Trzeciak MC et al. Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thromboasthenia undergoing invasive procedures. Thromb Haemost 2000; 83: 644-647.
    • (2000) Thromb Haemost , vol.83 , pp. 644-647
    • D'Oiron, R.1    Menart, C.2    Trzeciak, M.C.3
  • 22
    • 33749565827 scopus 로고    scopus 로고
    • Use of rFVIIa in 4 children with Glanzmann Thromboasthenia
    • Valentino LA. Use of rFVIIa in 4 children with Glanzmann Thromboasthenia. J Pediatr Hematol Oncol 2004: 28: 653-658.
    • (2004) J Pediatr Hematol Oncol , vol.28 , pp. 653-658
    • Valentino, L.A.1
  • 23
    • 0031826843 scopus 로고    scopus 로고
    • Treatment of a patient with Bernard-Soulier syndrome and recurrent nosebleeds with recombinant factor VIIa
    • Peters M, Heijboer H. Treatment of a patient with Bernard-Soulier syndrome and recurrent nosebleeds with recombinant factor VIIa. Thromb Haemost 1998; 80: 352.
    • (1998) Thromb Haemost , vol.80 , pp. 352
    • Peters, M.1    Heijboer, H.2
  • 24
    • 0001030560 scopus 로고    scopus 로고
    • Use of recombinant factor VIIa (NovoSeven®) for dental extraction in a patient affected by platelet-type (pseudo-) von Willebrand disease
    • Fressinaud E, Sigaud-Fiks M, Le Boterff C, Piot B. Use of recombinant factor VIIa (NovoSeven®) for dental extraction in a patient affected by platelet-type (pseudo-) von Willebrand disease. Haemophilia 1998; 4: 299.
    • (1998) Haemophilia , vol.4 , pp. 299
    • Fressinaud, E.1    Sigaud-Fiks, M.2    Le Boterff, C.3    Piot, B.4
  • 25
    • 0141887093 scopus 로고    scopus 로고
    • Management of thrombocytopenic bleeding: Is there a role for recombinant coagulation factor VIIa?
    • Poon MC. Management of thrombocytopenic bleeding: Is there a role for recombinant coagulation factor VIIa? Curr Hematol Rep 2003; 2: 139-147.
    • (2003) Curr Hematol Rep , vol.2 , pp. 139-147
    • Poon, M.C.1
  • 26
    • 0842299575 scopus 로고    scopus 로고
    • Experiences with recombinant human factor VIIa in patients with thrombocytopenia
    • Goodnough LT. Experiences with recombinant human factor VIIa in patients with thrombocytopenia. Semin Hematol 2004; 41 (Suppl. 1): S25-S29.
    • (2004) Semin Hematol , vol.41 , Issue.SUPPL. 1
    • Goodnough, L.T.1
  • 27
    • 0037337665 scopus 로고    scopus 로고
    • Recombinant factor VIIa for refractive haemorrhage in autoimmune idiopathic thrombocytopenic purpura
    • Culic S. Recombinant factor VIIa for refractive haemorrhage in autoimmune idiopathic thrombocytopenic purpura. Br J Haematol 2003; 120: 909-910.
    • (2003) Br J Haematol , vol.120 , pp. 909-910
    • Culic, S.1
  • 28
    • 33748490487 scopus 로고    scopus 로고
    • Experiences with recombinant activated factor VII in the treatment of severe refractory thrombocytopenia
    • Wrobel G, Dobaczewski G, Patkowski D, Sokol A, Grotthus E. Experiences with recombinant activated factor VII in the treatment of severe refractory thrombocytopenia. Pediatr Blood Cancer 2006; 47: 729-730.
    • (2006) Pediatr Blood Cancer , vol.47 , pp. 729-730
    • Wrobel, G.1    Dobaczewski, G.2    Patkowski, D.3    Sokol, A.4    Grotthus, E.5
  • 29
    • 9044221759 scopus 로고    scopus 로고
    • Clinical experience with recombinant factor VIIa in patients with thrombocytopenia
    • Kristensen J, Killander A, Hippe E et al. Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis 1996; 26 (Suppl. 1): S159-S164.
    • (1996) Haemostasis , vol.26 , Issue.SUPPL. 1
    • Kristensen, J.1    Killander, A.2    Hippe, E.3
  • 31
    • 2942611385 scopus 로고    scopus 로고
    • Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies
    • de Fabritiis P, Dentamaro T, Picardi A, Cudillo R, Maci M, Amadori S. Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies. Haematologica 2004; 89: 243-245.
    • (2004) Haematologica , vol.89 , pp. 243-245
    • de Fabritiis, P.1    Dentamaro, T.2    Picardi, A.3    Cudillo, R.4    Maci, M.5    Amadori, S.6
  • 32
    • 0036957457 scopus 로고    scopus 로고
    • Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa
    • Hicks K, Peng D, Gajewski JL. Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa. Bone Marrow Transplant 2002; 30: 975-978.
    • (2002) Bone Marrow Transplant , vol.30 , pp. 975-978
    • Hicks, K.1    Peng, D.2    Gajewski, J.L.3
  • 33
    • 0034072273 scopus 로고    scopus 로고
    • Recombinant factor VIIa for bleeding in refractory thrombocytopenia
    • Vidarsson B, Onundarson PT. Recombinant factor VIIa for bleeding in refractory thrombocytopenia. Thromb Haemost 2000; 83: 634-635.
    • (2000) Thromb Haemost , vol.83 , pp. 634-635
    • Vidarsson, B.1    Onundarson, P.T.2
  • 34
    • 0036177902 scopus 로고    scopus 로고
    • Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage
    • Gerotziafas GT, Zervas C, Gavrielidis G et al. Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage. Am J Hematol 2002; 69: 219-222
    • (2002) Am J Hematol , vol.69 , pp. 219-222
    • Gerotziafas, G.T.1    Zervas, C.2    Gavrielidis, G.3
  • 35
    • 27544461945 scopus 로고    scopus 로고
    • Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: An audit of the clinical use of recombinant activated factor VII
    • Brenner B, Hoffman R, Balashov D, Shutluko E, Culic SD, Nizamoutdinova E. Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: An audit of the clinical use of recombinant activated factor VII. Clin Appl Thromb Hemost 2005; 11: 401-410.
    • (2005) Clin Appl Thromb Hemost , vol.11 , pp. 401-410
    • Brenner, B.1    Hoffman, R.2    Balashov, D.3    Shutluko, E.4    Culic, S.D.5    Nizamoutdinova, E.6
  • 36
    • 33846034540 scopus 로고    scopus 로고
    • Massive pulmonary embolism after treatment with rFVIIa in a thrombocytopenic patient with acute myelogenous leukemia and intractable bleeding
    • Mantzios G, Tsirigotis P, Pappa V et al. Massive pulmonary embolism after treatment with rFVIIa in a thrombocytopenic patient with acute myelogenous leukemia and intractable bleeding. Eur J Haematol 2007; 78: 173-174.
    • (2007) Eur J Haematol , vol.78 , pp. 173-174
    • Mantzios, G.1    Tsirigotis, P.2    Pappa, V.3
  • 37
    • 33644515311 scopus 로고    scopus 로고
    • Combination therapy with rFVIIa and platelets for hemorrhage in patients with severe thrombocytopenia and alloimmunization
    • Savani BN, Dunbar CE, Rick ME. Combination therapy with rFVIIa and platelets for hemorrhage in patients with severe thrombocytopenia and alloimmunization. Am J Hematol 2006; 81: 218-219.
    • (2006) Am J Hematol , vol.81 , pp. 218-219
    • Savani, B.N.1    Dunbar, C.E.2    Rick, M.E.3
  • 40
    • 0036169161 scopus 로고    scopus 로고
    • Activated recombinant factor VII (rFVIIa) in bleeding management after therapy with IIb/IIIa-inhibitor tirofiban
    • Stepinska J, Banaszewski M, Konopka A, Szajewski T. Activated recombinant factor VII (rFVIIa) in bleeding management after therapy with IIb/IIIa-inhibitor tirofiban. Thromb Haemost 2002; 87: 355-356.
    • (2002) Thromb Haemost , vol.87 , pp. 355-356
    • Stepinska, J.1    Banaszewski, M.2    Konopka, A.3    Szajewski, T.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.